The global automated CPR devices market is estimated to be valued at US$ 127.6 million in 2023 and is expected to exhibit a CAGR of 11.5% during the forecast period (2023-2030).
Analysts’ Views on Global Automated CPR Devices Market Market:
Over the course of the forecast period, rising geriatric and cardiovascular disease incidence rates are anticipated to dominate global automated CPR devices market. The increasing geriatric population increases the demand for the use of automated CPR devices for the pateints which have cardiac disorders. For instance, in June 12, 2023, according to the British Heart Association, globally it’s estimated that 1 in 13 people are living with a heart or circulatory disease and there are around 620 million people living with heart and circulatory diseases across the world–this number has been rising due to changing lifestyles, an ageing and growing population, and improved survival rates from heart attacks and strokes and will continue to rise if these trends continue.
Figure 1. Global Automated CPR Devices Market Market Share (%), by Product Type, 2023
To learn more about this report, request a free sample copy
Global Automated CPR devices market– Driver
Increasing prevalence of cardiovascular disease (CVD)
Increasing incidence of cardiovascular diseases leads to the use of automated CPR devices is expected to boost growth of the global automated CPR devices market over the forecast period. For instance, in June 2021, according to the World Health Organization, an estimated 17.9 million people died from CVDs in 2020, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Over three quarters of CVD deaths take place in low and middle income countries such as Bangladesh, Afghanistan etc. Out of the 17 million premature deaths (under the age of 70) due to non-communicable diseases in 2020, 38% were caused by CVDs.
Innovation to the existing products
Certain factors such as innovation to the existing products of CPR, tended to drive the global automated CPR devices over the forecast period. For instance, in March 2021, NHS Tayside-a Health Board, InnoScot Health, a healthcare company, collaborated to design and develop the device SARUS-CPR hood that is set to revolutionise the resuscitation process for first responders. SARUS-CPR hood has been adopted into clinical practice by NHS Tayside following its development in response to the COVID-19 pandemic.
Figure 2. Global Automated CPR Devices Market Market Share (%), by Region, 2023
To learn more about this report, request a free sample copy
Global Automated CPR Devices Market Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global automated CPR devices market over the forecast period. North America is estimated to hold 42.5% of the market share. The North America automated CPR devices market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of cardiovascular diseases and increase in the geriatric population Thus, the rise in automated CPR devices market growth over the forecast period. For instance, on May 15, 2023, according to the Centers for Disease Control and Prevention, about 695,000 people in the U.S. died from heart disease in 2021—that’s 1 in every 5 death.
Global Automated CPR Devices Market Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another.
However, the COVID-19 pandemic had a positive impact on the global automated CPR devices market. The COVID-19 outbreak, led to the use of automated CPR devices for reducing the risk factors by providing necessary services to the pateints. For instance, in Decmber 2021, according to an article published in the Cardiology Journal, the prevalence and features of patients with severe COVID-19, it should be taken into account to do CPR on children infected with SARS-CoV-2, whose cardiac arrest may be caused by respiratory or other factors. As per the same source, similar guidelines to those for adults with SARS-CoV-2 infection are generally applicable, but extra focus should be placed on the child's airway, airway care, and quick identification of life-threatening symptoms.
Automated CPR Devices Market Market Report Coverage
|Market Size in 2023:
|US$ 127.6 Mn
|Historical Data for:
|2018 to 2021
|2023 to 2030
|Forecast Period 2023 to 2030 CAGR:
|2030 Value Projection:
|US$ 273.9 Mn
ZOLL Medical Corporation, Stryker, Brunswick MedTech, Michigan Instruments, SunLife Sciences Pvt Ltd., CPR Medical Devices, Inc., Medtronic, Faith Group, Nihon Kohden Corporation, SCHILLER Americas Inc.
|Restraints & Challenges:
Global Automated CPR Devices Market Market Segmentation:
The global automated CPR devices market report is segmented into by Product Type, by Compressor, By End User, and By Region.
By Product Type, the market is segmented into Load-Distributing Band (LDB) Devices, Piston CPR Devices, Active Compression-Decompression (ACD) Devices, Impedance Threshold Device, Extracorporeal Techniques & Invasive Perfusion Devices, Phased Thoracic-abdominal Compression-decompression CPR with a Handheld Device, and Others. Out of which, the Extracorporeal Techniques & Invasive Perfusion Devices segment is expected to hold a dominant position in the global automated CPR devices market during the forecast period and this is attributed due to the initiation of it emergently on patients who have had cardiac arrest.
By Compressor, the market is segmented into Automatic Mechanical CPR, Battery Driven, Pneumatic Driven, Mechanically Actuated & Battery Driven, and Manual CPR. Out of which, the battery driven segment is expected to hold a dominant position in the global automated CPR devices market during the forecast period and this is attributed to the increasing prevalence of cardiovascular diseases.
By End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Ambulance and Others. Out of which, the hospitals segment is expected to dominate the market over the forecast period and this is attributed to the admission rates in hospitals due to increase prevalence of cardiovasvular devices.
By Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Out of which, the North America is expected to dominated the global automated CPR devices market over the forecast period.
Among all the segmentations, the product type segment has the highest potential due to the emergently initiating action on patients who had cardiac arrest or any cardiac disease over the forecast period. For instance in Januray 2021, according to an article published in the Indian Journal of Thoracic and Cardiovascular Surgery, Extracorporeal cardiopulmonary resuscitation (ECPR) is a salvage procedure in which extracorporeal membrane oxygenation (ECMO) is initiated emergently on patients who have had cardiac arrest (CA) and on whom the conventional cardiopulmonary resuscitation (CCPR) has failed. This tends to increase the demand for the automated CPR devices over the forecast period.
Global Automated CPR Devices Market Market Cross Sectional Analysis:
Among, product type, Extracorporeal techniques & invasive perfusion devices expected to rise due to the rising incidence of cardiovascular diseases and increasing number of geriatric population is expected to boost demand for automated CPR devices market in North America region. For instance, on June 05, 2023, according to the Statista, in 2020, about 16.9 percent of the U.S population was 65 years old or over; a figure which is expected to reach 22 percent by 2050.
Global Automated CPR Devices Market Market: Key Developments
In November 2020, ZOLL Medical Corporation, a US-based manufacturer of critical care devices and systems partnered with BewellConnect, the e-health subsidiary of Visiomed Group, a developer of health products and services, for Resarch & Development of a mobile health solution that integrates ZOLL RescueNet AmbulancePad with BewellConnect VisioCheck for the French market.
In October 2022, LUCAS, annpunced the launch of the battery-powered device's for automated CPR. The LUCAS device eliminates the need to switch out CPR providers every two minutes and removes the effects of fatigue, individual variances, or psychological factors. Additionally, LUCAS offers superior and safer chest compressions in situations like patient movement and transportation, extended CPR, or the cath lab.
In February 2022, CPR Therapeutics Inc., a medical device company developing the next-generation system for cardiopulmonary resuscitation, announced that the company has received a U.S. patent for another component of technology that underlies its multimodal cardiopulmonary resuscitation (CPR) system: “Incorporation of the Electrodes for Defibrillation into the Patient-Facing Components of automated Cardiopulmonary Resuscitation Systems”. This multimodal CPR cannot be performed by humans, and significantly increases blood flow to the heart and brain while enhancing electrical countershock.
In September 2022, CPR Therapeutics Inc., a medical device company developing the next-generation system for cardiopulmonary resuscitation, announced that it has received a US$1.6M National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) Direct-To-Phase II Small Business Innovation Research Award for its project “A Multimodal Integrated System for Improved Cardiopulmonary Resuscitation.” The project will be conducted in collaboration with The Johns Hopkins Hospital in Baltimore, MD. CPR Therapeutics is developing multimodal cardiopulmonary resuscitation (CPR), a more effective form of automated mechanical CPR. Sudden cardiac arrest is the leading cause of death in western countries and there are currently no devices more effective than manual chest compressions. Intact survival after sudden cardiac arrest is below 10% in most communities.
Global Automated CPR Devices Market Market: Key Trends
Awareness Campaigns about CPR techniques
Increasing cardiovascular diseases had tended to look forward for the awareness campaigns to help the cardiovascular pateints about the CPR device techniques. For instance, on May 27, 2023, according to an American and Heart Association, conducted the 49th Emergency Medical Services (EMS) Week, which provide the awareness for the cardiovascular patients about the CPR devices techniques.
Global Automated CPR Devices Market: Restraint
High costs of automated CPR devices
High costs of automated CPR devices is slated to hinder market expansion. Due to the high cost of the automated CPR devices, it produces high chances of shifting from automated CPR devices to manual CPR devices leads to less efficacy as compared to automated CPR devices, which indirectly hinder the growth of the global automated CPR devices market. So, to avoid the high cost of the CPR, pneumatic and nonpneumatic circumferential chest compression, and minimally invasive cardiac massage these alternative techniques cane be employed. For instance, in December 2022, according to an article published by the Medwish.com, an online medical market that helps provide its customers with various medical devices and machines to facilitate the healthcare infrastructure, an average cost of an automated CPR device is US$ 10,000. Additional expenses are also required on replacement/disposable parts of CPR devices such as life band.
Global Automated CPR Devices Market Market- Key Players
Major players operating in the global automated CPR devices market include ZOLL Medical Corporation, Stryker, Brunswick MedTech, Michigan Instruments, SunLife Sciences Pvt Ltd., CPR Medical Devices, Inc., Medtronic, Faith Group, Nihon Kohden Corporation, and SCHILLER Americas Inc.
Frequently Asked Questions